Abstract:Aβ 1–42 is the proteolytic cleavage product of cleavage of the amyloid precursor protein by β- and γ-secretases. The aggregation of Aβ 1–42 plays a causative role in the development of Alzheimer’s disease. To lock Aβ 1–42 in a homogenous state, we embedded the Aβ 1–42 sequence in an unstructured region of Bcl-x L . Both the N-terminus and the C-terminus of Aβ 1–42 were constrained in the disordered region, whereas the conjunction did not introduce any folding to Aβ 1–42 but maintained the sequence as a monomer in solution. With Bcl-x L -Aβ 42 , we developed an enzyme-linked immunosorbent assay to compare the affinity of compounds for monomeric Aβ 1–42 . Bcl-x L -Aβ 42 was coated on a microplate and this was followed by incubation with different concentrations of compounds. Compounds binding to Leu17-Val24 of Aβ 1–42 inhibited the interaction between Bcl-x L -Aβ 42 and antibody 4G8. The method can not only reproduce the activities of the reported Aβ 1–42 inhibitors such as dopamine, tannin, and morin but can also differentiate decoy compounds that do not bind to Aβ 1–42 . Remarkably, using this method, we discovered a new inhibitor that binds to monomeric Aβ 1–42 and inhibits Aβ 1–42 fibril formation. As the structure of Bcl-x L -Aβ 42 monomer is stable in solution, the assay could be adapted for high-throughput screening with a series of antibodies that bind the different epitopes of Aβ 1–42 . In addition, the monomeric form of the Aβ 1–42 sequence in Bcl-x L -Aβ 42 would also facilitate the identification of Aβ 1–42 binding partners by coimmunoprecipitation, cocrystallization, surface plasmon resonance technology, or the assay as described here. Figure Schematic diagram of an enzyme-linked immunosorbent assay to compare the affinity of chemical compounds for β-amyloid peptide in monomer

Synthesis and Evaluation of Ferrocenoyl Pentapeptide (Fc-Klvff) As an Inhibitor of Alzheimer’s Aβ1–42 Fibril Formation in Vitro

Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro

Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Synthesis and Biological Evaluation of Deferiprone-Resveratrol Hybrids As Antioxidants, Aβ1–42 Aggregation Inhibitors and Metal-Chelating Agents for Alzheimer's Disease

An Enzyme-Linked Immunosorbent Assay To Compare The Affinity Of Chemical Compounds For Beta-Amyloid Peptide As A Monomer

Targeting the Amyloid-β Fibril Surface with a Constrained Helical Peptide Inhibitor.

Molecular Integrative Study on Inhibitory Effects of Pentapeptides on Polymerization and Cell Toxicity of Amyloid-β Peptide (1–42)

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Assembly of Nanoconjugates as New Kind Inhibitor of the Aggregation of Amyloid Peptides Associated with Alzheimer's Disease

An enzyme-linked immunosorbent assay to compare the affinity of chemical compounds for β-amyloid peptide as a monomer

Fusion of amyloid beta with ferritin yields an isolated oligomeric beta-sheet-rich aggregate inside the ferritin cage

Molecular Integrative Analysis of the Inhibitory Effects of Dipeptides on Amyloid β Peptide 1–42 Polymerization

Tuning Self-Assembled Morphology of the Aβ(16-22) Peptide by Substitution of Phenylalanine Residues.

Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease

Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization

Structural Optimization and Biological Evaluation of Substituted Bisphenol A Derivatives As Beta-Amyloid Peptide Aggregation Inhibitors.

Charged Tubular Supramolecule Boosting Multivalent Interactions for the Drastic Suppression of A beta Fibrillation

Synergistic Inhibitory Effect of Peptide-Organic Coassemblies on Amyloid Aggregation.

Α-Helical Motif As Inhibitors of Toxic Amyloid-β Oligomer Generation Via Highly Specific Recognition of Amyloid Surface